Trial intelligence / Profile preview

TRK-700 in Post-Herpetic Neuralgia

NCT02701374Phase 2Completed

Sponsor
Toray Industries
Start
Mar 2016
Primary completion
Jul 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of TRK-700 in postherpetic neuralgia (PHN), sponsored by Toray Industries. Started Mar 2016; status: completed.

02

Drugs

TRK-700
03

Conditions

postherpetic neuralgia (PHN)

Beyond the preview

Go deeper on NCT02701374.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02701374.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call